Antibody–drug conjugate, GSK2857916, in relapsed/refractory multiple myeloma: an update on safety and efficacy from dose expansion phase I study

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Blood Cancer Journal

Topics

Biology

Cancer Oncology

Medicine

Internal Medicine

Hematology

Show all topics

DOI

10.1038/s41408-019-0196-6

License

CC-BY

Other Formats

PDF